48 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
, global pandemics, including the COVID-19 pandemic and related strains, epidemic or similar health emergency, and other force majeure events
424B3
ORKA
Oruka Therapeutics Inc.
1 Aug 24
Prospectus supplement
4:10pm
the SARS-CoV-2 pandemic, we believe rNAPc2 has potential to be a beneficial therapy for patients with this serious viral disease. We initiated a Phase 2b
424B5
gsm2refmjuq xgg
18 Mar 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
q7czsoa ay716
14 Mar 22
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
4:26pm